Ledger.Open graph →
SEC Form D · filed January 31, 2018

Akriveia Therapeutics, LLC

Offering
$22.5M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SKILLMAN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Benjamin Auspitz · Skillman, NJDirectorThomas Beck · Skillman, NJDirectorSimon Tomlinson · Skillman, NJExec · DirectorDavid Grayzel · Cambridge, MADirectorModulus Capital Management, LP · Bellaire, TXDirectorEric M. Strzempek · Bloomfield Hills, MIExec · DirectorEric D. Rea · Lehi, UTDirectorMichael Gladstone · Skillman, NJDirectorErnest J. Morrison · Hamilton, BermudaDirectorPunit Dhillon · San Diego, CADirectorAvtar Dhillon · San Diego, CAExec · DirectorMichael Gladstone · Skillman, NJDirectorDavid Grayzel · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗